Start-up
inveox GmbH
Pathology 4.0 – The digital laboratory of the future
About inveox
Founded in Munich in 2017, inveox GmbH develops systems for the digitalization, automation and networking of pathology laboratories. The aim is to increase the safety and reliability of cancer diagnoses, while at the same time boosting the efficiency and profitability of laboratories and unlocking the potential for personalized diagnostics based on Big Data and Artificial Intelligence.
Since its inception, inveox has received a variety of awards, including "Startup of the Year 2017," "Top 50 Startups 2017" by For Founders, the " Golden Pretzel 2018" at Bits & Pretzels, and the 2019 EIT Health Award.
In 2018, inveox made it to the Forbes list of "most promising startups" and participated in the Roche Diagnostics/ "Plug&Play Digital Health Accelerator". Since 2019, inveox is a member of the World Economic Forum.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Founding: 2017
- Focus : Manufacturer
- Employees: 51-200
- Industry : Diagnostics, Laboratory equipment / supplies, Healthcare
